FDA Proposes Expanding Scope Of Clinical Investigator Disqualification In Regulations For New Animal Drugs For Investigational Use

ß

Jones Day

With this proposal, FDA intends to help ensure adequate protection of animal research subjects and the quality and integrity of data submitted to FDA.